Benefits From Sustained Virologic Response to Pegylated Interferon Plus Ribavirin in HIV/Hepatitis C Virus–Coinfected Patients With Compensated Cirrhosis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Benefits From Sustained Virologic Response to Pegylated Interferon Plus Ribavirin in HIV/Hepatitis C Virus–Coinfected Patients With Compensated Cirrhosis
Authors
Keywords
-
Journal
CLINICAL INFECTIOUS DISEASES
Volume 56, Issue 11, Pages 1646-1653
Publisher
Oxford University Press (OUP)
Online
2013-02-20
DOI
10.1093/cid/cit103
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis
- (2012) Nelson Cheinquer et al. Brazilian Journal of Infectious Diseases
- Response to Pegylated Interferon Plus Ribavirin Among HIV/Hepatitis C Virus-Coinfected Patients With Compensated Liver Cirrhosis
- (2012) J. A. Mira et al. CLINICAL INFECTIOUS DISEASES
- Increasing Incidence of Hepatocellular Carcinoma in HIV-Infected Patients in Spain
- (2012) Nicolás Merchante et al. CLINICAL INFECTIOUS DISEASES
- Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis
- (2012) Nicolás Merchante et al. HEPATOLOGY
- Relationship of Liver Disease Stage and Antiviral Therapy With Liver-Related Events and Death in Adults Coinfected With HIV/HCV
- (2012) Berkeley N. Limketkai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Direct-acting antivirals for hepatitis C virus infections in patients co-infected with human immunodeficiency virus
- (2012) Lionel Piroth Clinics and Research in Hepatology and Gastroenterology
- A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis C
- (2011) Lisa I. Backus et al. Clinical Gastroenterology and Hepatology
- Hepatitis C virus-human immunodeficiency virus coinfection
- (2011) Mark S. Sulkowski LIVER INTERNATIONAL
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Peginterferon Plus Ribavirin and Sustained Virological Response in HCV-Related Cirrhosis: Outcomes and Factors Predicting Response
- (2010) Conrado M Fernández-Rodríguez et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Causes of Death in HIV‐1–Infected Patients Treated with Antiretroviral Therapy, 1996–2006: Collaborative Analysis of 13 HIV Cohort Studies
- (2010) CLINICAL INFECTIOUS DISEASES
- Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis
- (2010) Ana-Carolina Cardoso et al. JOURNAL OF HEPATOLOGY
- Treatment of chronic hepatitis C in HIV-infected patients with compensated liver cirrhosis
- (2010) L. Martín-Carbonero et al. JOURNAL OF VIRAL HEPATITIS
- Natural History of Compensated Hepatitis C Virus–Related Cirrhosis in HIV‐Infected Patients
- (2009) Juan A. Pineda et al. CLINICAL INFECTIOUS DISEASES
- Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus
- (2009) Juan Berenguer et al. HEPATOLOGY
- Impact of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysis
- (2009) Li-Ping Deng et al. WORLD JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More